Orginal Article |
|
|
|
|
Optimized Yeast Expression of Canine Interferon-α Using a Combined Strategy |
LI Ding1,2,3,LI Lan1,2,3,AN Yun-fei4,BI Zhen-wei5,YU Xiao-ming1,2,3,CHEN Jin1,2,3,ZHENG Qi-sheng1,2,3,**() |
1 Institute of Veterinary Immunology & Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China 2 Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonose, Yangzhou University, Yangzhou 225009, China 3 Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base, Ministry of Science and Technology, Nanjing 210014, China 4 College of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China 5 Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China |
|
|
Abstract Canine interferon-α(CaIFN) was expressed in Pichia pastoris in the previous studies, which had high biological activity and relatively low yield. Therefore, increasing the yield of recombinant protein is the key task to promote the application of CaIFN. Yeast transformants containing 1, 2, 4, 6, and 8 copies of CaIFN gene were generated, and the yield of KM-6CaIFN was the highest, which was 200.6% higher than that of KM-1CaIFN. 8 molecular chaperones were co-expressed with CaIFN, and the Hac protein could increase the target protein yield of KM-6CaIFN and KM-8CaIFN by 32.1% and 113.1%, respectively. More copies of CaIFN were integrated into KM-8CaIFN-Hac strain. SDS-PAGE analysis showed that the yield of KM-12CaIFN-Hac was 1.33 times that of KM-8CaIFN-Hac, and 5.61 times that of KM-1CaIFN, respectively. By comparing protein bands with serially dilution BSA, the yield of KM-12CaIFN-Hac was estimated to be about 581 mg/L, which is the highest value in P. pastoris reported so far.
|
Received: 03 July 2021
Published: 03 March 2022
|
|
Corresponding Authors:
Qi-sheng ZHENG
E-mail: njcvc1302@163.com
|
|
|
[1] |
昝芳, 白海霞, 崔君. 天津地区犬常见传染病的调查及防控措施. 天津农学院学报, 2017, 24(4):90-93.
|
|
|
[1] |
Zan F, Bai H X, Cui J. Investigation and prevention control measures of common infectious diseases in canine in Tianjin area. Journal of Tianjin Agricultural University, 2017, 24(4):90-93.
|
|
|
[2] |
Borden E C. Interferons: rationale for clinical trials in neoplastic disease. Annals of Internal Medicine, 1979, 91(3):472.
pmid: 382941
|
|
|
[3] |
Tompkins W A. Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action. Journal of Interferon & Cytokine Research, 1999, 19(8):817-828.
|
|
|
[4] |
Carvalho O V, Saraiva G L, Ferreira C G T, et al. In-vitro antiviral efficacy of ribavirin and interferon-alpha against canine distemper virus. Canadian Journal of Veterinary Research, 2014, 78(4):283-289.
|
|
|
[5] |
Werten M W, van den Bosch T J, Wind R D, et al. High-yield secretion of recombinant gelatins by Pichia pastoris. Yeast (Chichester, England), 1999, 15(11):1087-1096.
doi: 10.1002/(ISSN)1097-0061
|
|
|
[6] |
Li D, Zhang B, Li S T, et al. A novel vector for construction of markerless multicopy overexpression transformants in Pichia pastoris. Frontiers in Microbiology, 2017, 8:1698.
doi: 10.3389/fmicb.2017.01698
|
|
|
[7] |
曹瑞兵, 王艳, 魏建超, 等. 犬α1干扰素在毕赤酵母中的分泌表达及其抗病毒活性研究. 南京农业大学学报, 2008, 31(4):107-112.
|
|
|
[7] |
Cao R B, Wang Y, Wei J C, et al. Secreted expression of canine interferon alpha subtype 1 in Pichia pastoris and its antiviral activity. Journal of Nanjing Agricultural University, 2008, 31(4):107-112.
|
|
|
[8] |
Li D, Zhang H M, Yang L, et al. Surface display of classical swine fever virus E2 glycoprotein on gram-positive enhancer matrix (GEM) particles via the SpyTag/SpyCatcher system. Protein Expression and Purification, 2020, 167:105526.
doi: 10.1016/j.pep.2019.105526
|
|
|
[9] |
Li D, Wu J C, Chen J, et al. Optimized expression of classical swine fever virus E2 protein via combined strategy in Pichia pastoris. Protein Expression and Purification, 2020, 167:105527.
doi: 10.1016/j.pep.2019.105527
|
|
|
[10] |
Guerfal M, Ryckaert S, Jacobs P P, et al. The HAC1 gene from Pichia pastoris: characterization and effect of its overexpression on the production of secreted, surface displayed and membrane proteins. Microbial Cell Factories, 2010, 9:49.
doi: 10.1186/1475-2859-9-49
pmid: 20591165
|
|
|
[11] |
Zhao H, Blazanovic K, Choi Y, et al. Gene and protein sequence optimization for high-level production of fully active and aglycosylated lysostaphin in Pichia pastoris. Applied and Environmental Microbiology, 2014, 80(9):2746-2753.
doi: 10.1128/AEM.03914-13
|
|
|
[12] |
Zhu T, Guo M, Tang Z, et al. Efficient generation of multi-copy strains for optimizing secretory expression of porcine insulin precursor in yeast Pichia pastoris. Journal of Applied Microbiology, 2009, 107(3):954-963.
doi: 10.1111/j.1365-2672.2009.04279.x
pmid: 19486418
|
|
|
[13] |
Delic M, Valli M, Graf A B, et al. The secretory pathway: exploring yeast diversity. FEMS Microbiology Reviews, 2013, 37(6):872-914.
doi: 10.1111/1574-6976.12020
|
|
|
[14] |
Zheng X Y, Zhang Y M, Zhang X Y, et al. Fhl1p protein, a positive transcription factor in Pichia pastoris, enhances the expression of recombinant proteins. Microbial Cell Factories, 2019, 18(1):207.
doi: 10.1186/s12934-019-1256-0
|
|
|
[15] |
Chang H J, Jones E W, Henry S A. Role of the unfolded protein response pathway in regulation of INO1 and in the sec14 bypass mechanism in Saccharomyces cerevisiae. Genetics, 2002, 162(1):29-43.
doi: 10.1093/genetics/162.1.29
pmid: 12242221
|
|
|
[16] |
Yu P, Zhu Q, Chen K F, et al. Improving the secretory production of the heterologous protein in Pichia pastoris by focusing on protein folding. Applied Biochemistry and Biotechnology, 2015, 175(1):535-548.
doi: 10.1007/s12010-014-1292-5
|
|
|
[17] |
Yin Y, Garcia M R, Novak A J, et al. Surf4 (Erv29p) binds amino-terminal tripeptide motifs of soluble cargo proteins with different affinities, enabling prioritization of their exit from the endoplasmic Reticulum. PLoS Biology, 2018, 16(8):e2005140.
doi: 10.1371/journal.pbio.2005140
|
|
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|